Package 21130-105-02

Brand: olopatadine hydrochloride ophthalmic solution

Generic: olopatadine hydrochloride ophthalmic
NDC Package

Package Facts

Identity

Package NDC 21130-105-02
Digits Only 2113010502
Product NDC 21130-105
Product ID 21130-105_ac0a51c9-185a-9d58-cb21-ee5b6a1134d6
Description

1 BOTTLE, PLASTIC in 1 CARTON (21130-105-02) / 2.5 mL in 1 BOTTLE, PLASTIC

Marketing

Marketing Status
Marketed Since 2021-06-25
Brand olopatadine hydrochloride ophthalmic solution
Generic olopatadine hydrochloride ophthalmic
Sample Package No

Linked Drug Pages (1)

Olopatadine Hydrochloride Ophthalmic Solution ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["OPHTHALMIC"], "spl_id": "ac0a51c9-185a-9d58-cb21-ee5b6a1134d6", "openfda": {"unii": ["2XG66W44KF"], "rxcui": ["1111343"], "spl_set_id": ["685192af-d729-3066-5825-6d0e03ce787e"], "manufacturer_name": ["Albertsons Companies"]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, PLASTIC in 1 CARTON (21130-105-02)  / 2.5 mL in 1 BOTTLE, PLASTIC", "package_ndc": "21130-105-02", "marketing_start_date": "20210625"}], "brand_name": "Olopatadine Hydrochloride Ophthalmic Solution", "product_id": "21130-105_ac0a51c9-185a-9d58-cb21-ee5b6a1134d6", "dosage_form": "SOLUTION", "pharm_class": ["Decreased Histamine Release [PE]", "Histamine H1 Receptor Antagonists [MoA]", "Histamine-1 Receptor Antagonist [EPC]", "Histamine-1 Receptor Inhibitor [EPC]", "Mast Cell Stabilizer [EPC]"], "product_ndc": "21130-105", "generic_name": "Olopatadine Hydrochloride Ophthalmic", "labeler_name": "Albertsons Companies", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Olopatadine Hydrochloride Ophthalmic Solution", "active_ingredients": [{"name": "OLOPATADINE HYDROCHLORIDE", "strength": "2 mg/mL"}], "application_number": "ANDA209752", "marketing_category": "ANDA", "marketing_start_date": "20210625", "listing_expiration_date": "20261231"}